Find Tenders for Medical equipments, pharmaceuticals and personal care products

NHS Greater Glasgow & Clyde OMS TPS Replacement

Description: Greater Glasgow Health Board (more commonly known as NHS Greater Glasgow and Clyde) operates the Beatson West of Scotland Cancer Centre (being the Gartnavel General Hospital and the Lanarkshire Beatson) and has a requirement to replace its treatment Oncology Management System (OMS) and Treatment Planning System (TPS) under the Scottish Government's Radiotherapy Capital Equipment Replacement Programme (CERP). This NHS Requirement includes the provision for the purchase of the following Products: Lot 1: Oncology Management System (OMS) and Record and Verify System (R&V) Lot 2: Treatment Planning System (TPS) Contractors may tender for any single, or both, lots. Separate tenders should be submitted for each lot. Contractors may submit more than 1 tender for any given lot. A single tender for more than 1 lot combined will not be (read more...)

Summary: NHS Greater Glasgow and Clyde is currently in the tender stage for the replacement of its Oncology Management System (OMS) and Treatment Planning System (TPS) at the Beatson West of Scotland Cancer Centre in Glasgow. This procurement is part of the Scottish Government’s Radiotherapy Capital Equipment Replacement Programme and falls under the healthcare industry category related to radiotherapy and physical therapy devices. The contract, valued at GBP 2.6 million, is divided into two lots, each with a contract duration of two years. Businesses interested in participating must submit their tenders electronically by 2nd June 2026, with the award decision and bid opening also taking place on the same date. The process is conducted through an open procurement method, allowing any qualified supplier to bid, and is covered by the GPA trade agreement.

T167 Supply and Delivery of Lenticules

Description: This contract is for the supply and delivery of Lenticules. Further information can be found in Schedule 1 - Specification.

Summary: Northern Ireland Water Limited, a sub-central government public authority, is currently initiating a tender for the "T167 Supply and Delivery of Lenticules". This procurement process is focused on the goods category, particularly involving microbiological cultures, laboratory reagents, laboratory services, and chemical products. The contract location is Belfast, United Kingdom, with the procurement method being an open competition below the threshold. Interested parties must submit their bids via https://etendersni.gov.uk by 23:59 on 22nd May 2026, with any enquiries to be submitted by 15th May 2026. The successful bidder will commence the contract from 7th September 2026, with it running until 6th September 2029, with an extension option available for up to two additional years.

PHW-FTS-62033 - HCV LATERAL FLOW TESTS

Description: Public Health Wales (PHW) is committed to supporting the national Blood-Borne Virus (BBV) screening services, including for HIV, Hepatitis B (HBV), Hepatitis C (HCV), and syphilis. collection and analysis of samples across our screening programs. The timely and efficient processing of these samples is critical to achieving the World Health Organization's (WHO) ambitious elimination targets for HIV, HBV, HCV, and syphilis. As part of this, Welsh Government produced a circular mandating that Welsh Prisons achieve and maintain elimination of Hepatitis C amongst the prison population. Public Health Wales have been supporting this effort and have begun to introduce this test as part of the general community Point of Care testing pathway. Use of an oral swab as opposed to a needle or finger price test supports wider usage (read more...)

Summary: The NHS Wales is initiating a procurement process titled "PHW-FTS-62033 - HCV LATERAL FLOW TESTS," which aims to support Blood-Borne Virus (BBV) screening services, crucial for combating diseases like HIV, Hepatitis B, Hepatitis C, and syphilis. The buying organisation is the Public Health Wales NHS Trust, headquartered in Cardiff, United Kingdom. The tender is categorized under miscellaneous medical devices and products, with an emphasis on community-based testing. The key procurement stage is the tender phase, with the procurement method described as an open procedure. Interested parties should note several important dates: the submission deadline is set for 2nd June 2026 at 12:00 pm, while the contract is scheduled to commence on 1st September 2026 and conclude on 31st August 2029.

Single-molecule counting and digital quantification of RNA molecules instrument

Description: The Contracting Authority requires a multiplexed molecular analysis system capable of performing direct, amplification-free, digital quantification of gene expression (mRNA and miRNA) and protein targets from limited and potentially degraded clinical samples. The system will be used primarily for patient-derived specimens, including FFPE and other clinically archived materials, where RNA quantity and integrity may be limited. The solution must therefore demonstrate high sensitivity, reproducibility, and robustness to sample degradation. The required system must provide a complete sample-to-data workflow, enabling end-to-end processing, automated or semi-automated operation, and integrated data analysis suitable for use by scientific staff without advanced bioinformatics expertise. To access this opportunity, you must first register as a "Supplier" on the Authority's e-tendering portal here: https://atamis-1928.my.site.com/s/Welcome

Summary: The current procurement process is initiated by the Secretary of State for Health and Social Care, acting as part of the Crown through the UK Health Security Agency, located in London, United Kingdom. The active tender is for a "Single-molecule counting and digital quantification of RNA molecules instrument" intended for medical equipment use. The procurement is in the tender stage and operates under an open procedure, inviting submissions via a specified e-tendering portal. The tender period concludes on 28th May 2026, and the award is expected by 10th June 2026. This procurement is of particular interest to businesses specializing in high-sensitivity molecular analysis systems, given the instrument's stringent requirements for sensitivity, reproducibility, and robustness.

NHS Greater Glasgow & Clyde OMS TPS Replacement

Description: Greater Glasgow Health Board (more commonly known as NHS Greater Glasgow and Clyde) operates the Beatson West of Scotland Cancer Centre (being the Gartnavel General Hospital and the Lanarkshire Beatson) and has a requirement to replace its treatment Oncology Management System (OMS) and Treatment Planning System (TPS) under the Scottish Government's Radiotherapy Capital Equipment Replacement Programme (CERP). This NHS Requirement includes the provision for the purchase of the following Products: Lot 1: Oncology Management System (OMS) and Record and Verify System (R&V) Lot 2: Treatment Planning System (TPS) Contractors may tender for any single, or both, lots. Separate tenders should be submitted for each lot. Contractors may submit more than 1 tender for any given lot. A single tender for more than 1 lot combined will not be (read more...)

Summary: NHS Greater Glasgow and Clyde is seeking tenders for the replacement of its Oncology Management System (OMS) and Treatment Planning System (TPS) as part of the Scottish Government’s Radiotherapy Capital Equipment Replacement Programme (CERP). The procurement process is in the tender stage and involves two main lots: Lot 1 for an OMS and Record and Verify System, and Lot 2 for a TPS. The estimated value of the contract is £2.6 million, with the delivery location at the Beatson West of Scotland Cancer Centre in Glasgow. Interested parties must submit their tenders electronically by 11:00 on 2nd June 2026. The procurement is being conducted through an open procedure, ensuring transparent and competitive bidding.

UoD-EFM158-TC-2026 - NTRL Sample Transport

Description: As part of Scotland's national public health response to drug-related harms, the University will host the National Testing and Research Laboratory (NTRL) within the Leverhulme Research Centre for Forensic Science. The NTRL will operate as a specialist forensic chemical laboratory providing confirmatory qualitative and quantitative analysis of suspected controlled drug samples submitted through Scotland's Drug Checking Pilot. This procurement seeks to appoint a suitably qualified and authorised Contractor to provide secure, compliant, and time-sensitive transport services in support of the NTRL's operational function.

Summary: The University of Dundee, a body governed by public law in the education sector, is initiating a tender process titled "UoD-EFM158-TC-2026 - NTRL Sample Transport." This procurement involves contracting services for secure and timely transportation to support the National Testing and Research Laboratory's (NTRL) functions, as part of Scotland's public health initiative against drug-related harms. The tender, based in Dundee, falls under the services category and employs an open procedure method, with an end date for submissions on 3rd June 2026 at noon. The contract is valued at £110,000 and the selected contractor will have a period of 1080 days for contract execution, starting from the awarding date of 3rd June 2026.

NHS National Framework for Ruxolitinib

Description: Project title: NHS National Framework for Ruxolitinib Offer reference number: CM/TNS/26/5755 Period of framework: 1 November 2026 to 31 October 2027 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Summary: NHS England is initiating a procurement process titled "NHS National Framework for Ruxolitinib" as part of their planning stage. This tender is intended for the pharmaceutical industry, specifically focusing on the procurement of pharmaceutical products across various regions in the United Kingdom, including UKC, UKD, UKF, UKG, UKH, UKJ, and UKK. The procurement falls under the category of goods and involves an open procedure. The framework is scheduled to commence on 1 November 2026 and end on 31 October 2027, with the possibility of extension up to an additional 24 months. A virtual preliminary market engagement meeting is planned for interested suppliers, with a due date for registration by 15 May 2026. Future notices regarding the procurement exercise are expected by 30 June 2026. NHS England, as a central government public authority, is seeking to engage suppliers for the delivery of pharmaceutical products under this framework, and queries can be directed to their Medicines Procurement and Supply Chain team.

Postural Management Equipment and Accessories

Description: Business Services Organisation (BSO), Procurement and Logistics Service (PaLS) is seeking to establish a Framework for the supply and delivery of Postural Management Equipment and Accessories

Summary: The Belfast Health and Social Care Trust, along with other trusts such as Northern, Southeastern, Southern, and Western Health and Social Care Trusts, is overseeing an extensive procurement process for Postural Management Equipment and Accessories under the initiation type 'tender'. This tender is managed by the Business Services Organisation Procurement and Logistics Service. Classified within the medical equipment and pharmaceuticals sector, the tender is part of an active planning stage. The total estimated contract value is £31,000,000, with the procurement process employing an open procedure to establish a framework agreement. The inquiry and tender periods conclude on 21 May 2026 and 2 June 2026, respectively, ensuring ample time for interested parties to submit their bids. This procurement is specific to Northern Ireland, aligning with regional regulations, and involves a comprehensive range of medical devices, furniture, and related products.

IV Cannulae and Associated Infusion Set

Description: Business Services Organisation (BSO), Procurement and Logistics Service (PaLS) is seeking to establish a Framework Agreement for the supply and delivery of IV Cannulae and Associated Infusion Set to Health and Social Care Trusts within Northern Ireland.

Summary: The Business Services Organisation Procurement and Logistics Service is actively seeking to establish a Framework Agreement for the supply and delivery of IV Cannulae and Associated Infusion Sets to various Health and Social Care Trusts within Northern Ireland. The procurement is currently at the tender stage with key activities scheduled, including the tender period closing on 1st June 2026 and the award period concluding by 1st July 2026. This open procedure procurement, managed under Northern Irish devolved regulations, focuses on the goods category specifically pertaining to medical devices and products. The initiative involves multiple Trusts in Belfast, Antrim, Londonderry, and Portadown, serving as evaluators during the tender assessment process.

Property Works

Description: The Property Works Dynamic Market is organised into five themes that reflect the lifecycle of property maintenance and improvement. Each theme addresses a specific facet of asset management, from initial assessment and compliance to the installation of modern, sustainable infrastructure. Designed to ensure that PfP and other Public Sector Bodies have access to a robust supply chain of qualified and experienced service providers. Within those 5 themes there are 20 Lots: Theme 1: Professional Surveys and Compliance * Lot 1 - Stock Condition Surveys * Lot 2 - Energy Performance Certificates * Lot 3 - Fire Risk Assessments Theme 2: General Building and External Works * Lot 4 - Structural Works * Lot 5 - External Fabric * Lot 6 - Environmental & Landscaping * Lot 7 - (read more...)

Summary: The procurement process initiated by Places for People Group Limited involves an active tender for "Property Works," focusing on building services and energy-related tasks. The tender encompasses five primary themes divided into 20 lots, aimed at property maintenance, improvement, and sustainable infrastructure across regions, including the United Kingdom, Guernsey, Isle of Man, Jersey, and Gibraltar. The procurement is in the "tender" stage with key details accessible via their website. This open dynamic market commences on 1st July 2026 and concludes on 30th June 2036, with submissions permitted electronically.